Search research articles
Contact Us
Filters
Showing results (21-30 of 83) with videos related to
Page
of 9
Sort By:
American Journal of Blood Research
|
July 11, 2017
Erratum: Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia
Borhane Slama, Olivier Fain, Hervé Maisonneuve, et al.
Blood
|
January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
Mohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
Ejhaem
|
August 21, 2023
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
Shanti Amé, Fiorenza Barraco, Jean-Christophe Ianotto, et al.
Molecular Cancer Therapeutics
|
November 4, 2010
Exon 7 deletion in the bcr-abl gene is frequent in chronic myeloid leukemia patients and is not correlated with resistance against imatinib
Jean-Baptiste Gaillard, Cécile Arnould, Sophie Bravo, et al.
International Journal of Hematology
|
September 5, 2003
Survival and proliferation factors of normal and malignant plasma cells
Bernard Klein, Karin Tarte, Michel Jourdan, et al.
Leukemia & Lymphoma
|
November 5, 2013
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Eric Jourdan, Veronique Leblond, Hervé Maisonneuve, et al.
Dermatology and Therapy
|
August 24, 2023
Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies
Anthony Brown, Marta Furmanczyk, David Ramos, et al.
Blood
|
April 9, 2004
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
Jérôme Moreaux, Eric Legouffe, Eric Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study
Bertrand Coiffier, Nicolas Mounier, Serge Bologna, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
Page
of 9
Search research articles
Search
Showing results (21-30 of 83) with videos related to
Sort By:
Page
of 9
American Journal of Blood Research
|
July 11, 2017
Erratum: Efficacy and safety of ClairYg®, a ready-to-use intravenous immunoglobulin, in adult patients with primary immune thrombocytopenia
Borhane Slama, Olivier Fain, Hervé Maisonneuve, et al.
Blood
|
January 13, 2004
Imatinib and plasmacytoid dendritic cell function in patients with chronic myeloid leukemia
Mohamad Mohty, Eric Jourdan, Naira Ben Mami, et al.
Ejhaem
|
August 21, 2023
Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice
Shanti Amé, Fiorenza Barraco, Jean-Christophe Ianotto, et al.
Molecular Cancer Therapeutics
|
November 4, 2010
Exon 7 deletion in the bcr-abl gene is frequent in chronic myeloid leukemia patients and is not correlated with resistance against imatinib
Jean-Baptiste Gaillard, Cécile Arnould, Sophie Bravo, et al.
International Journal of Hematology
|
September 5, 2003
Survival and proliferation factors of normal and malignant plasma cells
Bernard Klein, Karin Tarte, Michel Jourdan, et al.
Leukemia & Lymphoma
|
November 5, 2013
A multicenter phase II study of single-agent enzastaurin in previously treated multiple myeloma
Eric Jourdan, Veronique Leblond, Hervé Maisonneuve, et al.
Dermatology and Therapy
|
August 24, 2023
Natural Retinol Analogs Potentiate the Effects of Retinal on Aged and Photodamaged Skin: Results from In Vitro to Clinical Studies
Anthony Brown, Marta Furmanczyk, David Ramos, et al.
Blood
|
April 9, 2004
BAFF and APRIL protect myeloma cells from apoptosis induced by interleukin 6 deprivation and dexamethasone
Jérôme Moreaux, Eric Legouffe, Eric Jourdan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 29, 2003
Efficacy and safety of rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study
Bertrand Coiffier, Nicolas Mounier, Serge Bologna, et al.
Haematologica
|
November 21, 2007
Adding lomustine to idarubicin and cytarabine for induction chemotherapy in older patients with acute myeloid leukemia: the BGMT 95 trial results
Arnaud Pigneux, Virginie Perreau, Eric Jourdan, et al.
Page
of 9